vTv Therapeutics Inc. (VTVT) Financials

$13.53

north_east $0.13 (0.96%)
Day's range
$13.25
Day's range
$14.27

VTVT Income statement / Annual

Last year (2023), vTv Therapeutics Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2023, vTv Therapeutics Inc.'s net income was -$20.25 M. See vTv Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $2.02 M $4.01 M $6.41 M $2.76 M $12.43 M $291,000.00 $634,000.00 $519,000.00 $1.55 M
Cost of Revenue $13.60 M $92,000.00 $89,000.00 $11.02 M $15.12 M $23.04 M $39.64 M $45.75 M $29.58 M $18.73 M
Gross Profit -$13.60 M $1.93 M $3.92 M -$4.60 M -$12.36 M -$10.60 M -$39.35 M -$45.11 M -$29.07 M -$17.18 M
Gross Profit Ratio 0 0.95 0.98 -0.72 -4.47 -0.85 -135.22 -71.16 -56 -11.09
Research and Development Expenses $13.60 M $12.36 M $13.32 M $11.02 M $15.12 M $23.04 M $39.64 M $45.75 M $29.58 M $18.73 M
General & Administrative Expenses $11.91 M $12.20 M $12.34 M $7.25 M $8.54 M $9.22 M $11.33 M $9.91 M $9.08 M $11.72 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $11.91 M $12.20 M $12.34 M $7.25 M $8.54 M $9.22 M $11.33 M $9.91 M $9.08 M $11.72 M
Other Expenses -$13.60 M -$2.67 M $4.06 M -$270,000.00 $828,000.00 -$592,000.00 -$190,000.00 -$22,000.00 -$2.97 M -$1.13 M
Operating Expenses $11.91 M $24.56 M $25.67 M $18.27 M $23.66 M $32.26 M $50.97 M $55.65 M $38.66 M $30.45 M
Cost And Expenses $25.50 M $24.56 M $25.67 M $18.27 M $23.66 M $32.26 M $50.97 M $55.65 M $38.66 M $30.45 M
Interest Income $472,000.00 $352,000.00 $1,000.00 $12,000.00 $53,000.00 $61,000.00 $117,000.00 $87,000.00 $0.00 $0.00
Interest Expense $13,000.00 $15,000.00 $12,000.00 $692,000.00 $1.83 M $3.29 M $3.09 M $398,000.00 $1.74 M $6.01 M
Depreciation & Amortization $90,000.00 $92,000.00 $89,000.00 $94,000.00 $39,000.00 $218,000.00 $197,000.00 $265,000.00 $501,000.00 $864,000.00
EBITDA -$25.41 M -$24.77 M -$17.52 M -$12.02 M -$19.97 M -$20.14 M -$50.56 M -$54.69 M -$38.87 M -$29.23 M
EBITDA Ratio 0 -12.32 -4.4 -1.89 -7.24 -1.64 -174.42 -86.68 -73.49 -18.82
Operating Income Ratio 0 -11.17 -5.41 -1.85 -7.56 -1.59 -174.16 -86.78 -73.49 -18.66
Total Other Income/Expenses Net -$464,000.00 -$2.33 M $4.05 M -$950,000.00 -$946,000.00 -$3.82 M -$3.17 M -$333,000.00 -$2.97 M -$7.20 M
Income Before Tax -$25.97 M -$24.87 M -$17.62 M -$12.80 M -$21.84 M -$23.65 M -$53.85 M -$55.35 M -$41.11 M -$36.10 M
Income Before Tax Ratio 0 -12.33 -4.4 -2 -7.9 -1.9 -185.04 -87.31 -79.2 -23.31
Income Tax Expense $0.00 $200,000.00 $115,000.00 -$3.98 M $100,000.00 $200,000.00 $800,000.00 -$39.00 M -$14.11 M $4.88 M
Net Income -$20.25 M -$25.07 M -$17.73 M -$8.83 M -$21.94 M -$7.91 M -$16.14 M -$16.35 M -$27.50 M -$36.10 M
Net Income Ratio 0 -12.42 -4.43 -1.38 -7.94 -0.64 -55.48 -25.79 -52.98 -23.31
EPS -9.71 -13.06 -11.32 -7.49 -28.97 -25.42 -66.62 -68.52 -132.9 -173.87
EPS Diluted -9.71 -13.06 -11.32 -7.49 -28.97 -25.42 -66.62 -68.52 -132.9 -173.87
Weighted Average Shares Out $2.08 M $1.92 M $1.57 M $1.18 M $757,301.00 $311,231.00 $242,330.00 $238,638.00 $206,913.00 $207,633.00
Weighted Average Shares Out Diluted $2.08 M $1.92 M $1.57 M $1.18 M $757,301.00 $311,231.00 $242,331.00 $238,638.00 $206,913.00 $207,633.00
Link